Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lenalidomide Treatment for Multiple Myeloma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors
Keywords
Multiple myeloma, Adverse events, Meta-analysis, Cancer treatment, Deep vein thrombosis, Hematology, Neutropenia, Randomized controlled trials
Journal
PLoS One
Volume 8, Issue 5, Pages e64354
Publisher
Public Library of Science (PLoS)
Online
2013-05-15
DOI
10.1371/journal.pone.0064354
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Concepts of Clinical Management of Multiple Myeloma
- (2012) Sai Ravi Pingali et al. DM DISEASE-A-MONTH
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of the adverse effects of lenalidomide in multiple myeloma
- (2011) Ana Pilar González Rodríguez ADVANCES IN THERAPY
- Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
- (2011) N. C. Munshi et al. BLOOD
- Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide
- (2011) A. Larocca et al. BLOOD
- Multiple Myeloma: Current Perspectives
- (2011) Marilyn L. Slovak CLINICS IN LABORATORY MEDICINE
- Lenalidomide
- (2011) Lesley J. Scott et al. DRUGS
- Lenalidomide in multiple myeloma: current experimental and clinical data
- (2011) Mauro Cives et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232)
- (2010) J. A. Zonder et al. BLOOD
- Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
- (2009) F. Gay et al. BLOOD
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure
- (2008) M. Wang et al. BLOOD
- New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
- (2008) Enrique M Ocio et al. LANCET ONCOLOGY
- Treatment of newly diagnosed myeloma
- (2008) A Palumbo et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now